Basic Information
Basic information for SOX2-OT-252-69aa
Peptide Name SOX2-OT-252-69aa
Genome Position chr3:181699721-181699883,181715185-181715228[+]
Species Human
Peptide Sequence MKDERGTASSFNWFCPVRSDQAWADKRLREPSRSFAFLPANQTATRQHPDLAWTSRVQACSPKSDNLCS
Peptide Length 69
Unique No (SOX2-OT-218-69aa,SOX2-OT-220-69aa,SOX2-OT-228-69aa,SOX2-OT-232-69aa,SOX2-OT-234-69aa,SOX2-OT-238-69aa,SOX2-OT-239-69aa,SOX2-OT-243-69aa,SOX2-OT-248-69aa,SOX2-OT-250-69aa,SOX2-OT-253-69aa,SOX2-OT-261-69aa,SOX2-OT-263-69aa,SOX2-OT-276-69aa,SOX2-OT-283-69aa,SOX2-OT-292-69aa,SOX2-OT-293-69aa,SOX2-OT-294-69aa,SOX2-OT-295-69aa,SOX2-OT-296-69aa,SOX2-OT-299-69aa,SOX2-OT-303-69aa,SOX2-OT-304-69aa)
Grand Average of Hydropathicity -0.8391
Relative Molecular Mass 9084.83
Experimental Evidences 3:lncORF,m6A,ribo
lncRNA ID/Name ENSG00000242808;SOX2-OT
Transcript ID/Name ENST00000629552;SOX2-OT-252
Transcript Length 572
Coding Ability 0.3619
DNA Sequence Corresponding to Peptide ATGAAGGACGAGAGGGGAACTGCAAGCTCCTTCAACTGGTTCTGTCCGGTGAGAAGTGATCAAGCTTGGGCTGACAAGAGGCTCAGGGAGCCCTCACGTTCTTTCGCTTTTTTACCTGCCAATCAAACTGCTACAAGACAACACCCTGATCTGGCATGGACATCGCGGGTCCAAGCCTGTAGCCCCAAATCGGATAATCTCTGCAGC
Experimental Evidences
   lncORF
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :